Clinical Trial Update: A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmatic Adolescent and Adult Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pharmacokinetics, pharmacodynamics, and safety of CHF 1535 (beclomethasone + formoterol) via NEXT DPI vs. free combination in asthmatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone DPI (beclomethasone)
• CHF 1535 (Fixed Combination of Beclomethasone + Formoterol)
• Formoterol DPI (formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED